000 | 01908 a2200517 4500 | ||
---|---|---|---|
005 | 20250513091336.0 | ||
264 | 0 | _c19960725 | |
008 | 199607s 0 0 eng d | ||
022 | _a0021-9738 | ||
024 | 7 |
_a10.1172/JCI118691 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYamamoto, K | |
245 | 0 | 0 |
_aFibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. _h[electronic resource] |
260 |
_bThe Journal of clinical investigation _cJun 1996 |
||
300 |
_a2440-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdrenal Glands _xdrug effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aDNA Primers |
650 | 0 | 4 |
_aEndotoxins _xpharmacology |
650 | 0 | 4 | _aEscherichia coli |
650 | 0 | 4 |
_aFibrin _xanalysis |
650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aIn Situ Hybridization |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 | _aOrgan Specificity |
650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xbiosynthesis |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xbiosynthesis |
650 | 0 | 4 |
_aTransferrin _xbiosynthesis |
650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xbiosynthesis |
700 | 1 | _aLoskutoff, D J | |
773 | 0 |
_tThe Journal of clinical investigation _gvol. 97 _gno. 11 _gp. 2440-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI118691 _zAvailable from publisher's website |
999 |
_c8646972 _d8646972 |